|
C10ORF119 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.475800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.411030E-01 |
| Normal-vs-Stage2 |
2.086000E-02 |
| Normal-vs-Stage3 |
5.029700E-02 |
| Normal-vs-Stage4 |
1.418970E-01 |
| Stage1-vs-Stage2 |
1.152750E-01 |
| Stage1-vs-Stage3 |
3.679600E-01 |
| Stage1-vs-Stage4 |
6.810800E-01 |
| Stage2-vs-Stage3 |
4.219400E-01 |
| Stage2-vs-Stage4 |
3.391000E-01 |
| Stage3-vs-Stage4 |
7.977800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.683600E-02 |
| Normal-vs-AfricanAmerican |
8.961400E-01 |
| Normal-vs-Asian |
5.604800E-01 |
| Caucasian-vs-AfricanAmerican |
2.217400E-01 |
| Caucasian-vs-Asian |
4.102800E-01 |
| AfricanAmerican-vs-Asian |
5.955200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.486100E-02 |
| Normal-vs-Female |
8.884200E-02 |
| Male-vs-Female |
2.922200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.468000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.496000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.896300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.972400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.444200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.902590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.587000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.468600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.342600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.555200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.977400E-01 |
| Classical-VS-Follicular |
7.70000000427373E-08 |
| Classical-VS-Other |
2.944400E-01 |
| Classical-VS-Normal |
6.977800E-01 |
| Tall-VS-Follicular |
2.836600E-03 |
| Tall-VS-Other |
3.321800E-01 |
| Tall-VS-Normal |
7.776800E-01 |
| Follicular-VS-Other |
4.917600E-01 |
| Follicular-VS-Normal |
5.90309999999317E-05 |
| Other-VS-Normal |
1.858650E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.941800E-03 |
| Normal-vs-N1 |
6.127600E-02 |
| N0-vs-N1 |
8.686800E-01 |
|
|
